Citius Pharmaceuticals, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $349.25K, a 86.43% decline year-over-year.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.29M, a 75.99% decline year-over-year.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $3.47M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $2.57M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2024 was $13.80M, a 0.04% increase from fiscal 2023.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2023 was $13.80M.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2021 was $500.00, a 99.99% decline from fiscal 2020.
- Citius Pharmaceuticals, Inc. stock issued during period, value, new issues for fiscal 2020 was $8.70M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $349.25K 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $3.29M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $3.47M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $2.57M 10-Q · filed 2026-05-15 | |
| 2024-09-30 | $13.80M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $13.72M 10-Q · filed 2024-08-12 | |
| 2023-09-30 | $13.80M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $13.80M 10-Q · filed 2024-08-12 | |
| 2021-09-30 | $500.00 10-K · filed 2022-12-22 | |
| 2020-12-31 | $500.00 10-Q · filed 2022-08-11 | |
| 2020-09-30 | $8.70M 10-K · filed 2021-12-15 | |
| 2019-06-30 | $4.83M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $1.76M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $5.48M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $69.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $491.35K 10-K · filed 2019-12-16 |
| 2016-09-30 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $4.23M 10-K · filed 2018-12-11 |
| 2015-09-30 | $741.06K 10-K · filed 2017-12-13 | |
| 2010-09-30 | $18.00K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |